Chronic carbon monoxide treatment attenuates development of obesity and remodels adipocytes in mice fed a high-fat diet

International Journal of Obesity

Volumn 38, Issue 1, 2014, Pages 132-139

  Hosick, P A ^a   Alamodi, A A ^a   Storm, M V ^a   Gousset, M U ^a   Pruett, B E ^a   Gray, W ^a   Stout, J ^a   Stec, D E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

diabetes; heme oxygenase; insulin resistance; metabolism; oxygen consumption

Indexed keywords

ADIPONECTIN; CARBON DIOXIDE; CARBON MONOXIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBRONECTIN; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRANSCRIPTION FACTOR NRF1; UNCOUPLING PROTEIN 1; VASCULOTROPIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOGENESIS; BODY COMPOSITION; BODY FAT; BODY TEMPERATURE; BODY WEIGHT; CONTROLLED STUDY; CYTOLOGY; DISEASE COURSE; EPIDIDYMIS FAT; FAT MASS; FOOD INTAKE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LIPID DIET; MALE; METABOLISM; MOTOR ACTIVITY; MOUSE; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; THERMOGENESIS; WEIGHT GAIN;

MUS; RODENTIA;

ADIPOCYTES; ANIMALS; BIOGENESIS; BLOOD GLUCOSE; BLOTTING, WESTERN; BORANES; CARBON MONOXIDE; CARBONATES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; EATING; HEME OXYGENASE-1; MALE; MICE; MICE, INBRED C57BL; OBESITY; UP-REGULATION; WEIGHT LOSS;

EID: 84891824888     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2013.61     Document Type: Article

References (41)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428.
2. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
3. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: a putative neural messenger. Science 1993; 259: 381-384.
4. Johnson RA, Colombari E, Colombari DS, Lavesa M, Talman WT, Nasjletti A. Role of endogenous carbon monoxide in central regulation of arterial pressure. Hypertension 1997; 30: 962-967.
5. Morse D, Sethi J, Choi AM. Carbon monoxide-dependent signaling. Crit Care Med 2001; 30: S12-S17.
6. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008; 60: 79-127.
7. Kaide JI, Zhang F, Wei Y, Jiang H, Yu C, Wang WH et al. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 2001; 107: 1163-1171.
8. Parfenova H, Neff 3rd RA, Alonso JS, Shlopov BV, Jamal CN, Sarkisova SA et al. Cerebral vascular endothelial heme oxygenase: expression, localization, and activation by glutamate. Am J Physiol Cell Physiol 2001; 281: C1954-C1963.
9. Peterson SJ, Drummond G, Kim DH, Li M, Kruger AL, Ikehara S et al. L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice. J Lipid Res 2008; 49: 1658-1669.
10. Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Rodella LF et al. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 2008; 57: 1526-1535.
11. Burgess A, Li M, Vanella L, Kim DH, Rezzani R, Rodella L et al. Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice. Hypertension 2010; 56: 1124-1130.
12. Csongradi E, Docarmo JM, Dubinion JH, Vera T, Stec DE. Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice. Int J Obes (Lond) 2011; 36: 244-253.
13. Cao J, Peterson SJ, Sodhi K, Vanella L, Barbagallo I, Rodella LF et al. Heme oxygenase gene targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet. Hypertension 2012; 60: 467-475.
14. Pitchumony TS, Spingler B, Motterlini R, Alberto R. Syntheses, structural characterization and CO releasing properties of boranocarbonate [H3BCO2H]-derivatives. Org Biomol Chem 2010; 8: 4849-4854.
15. Vummaleti SV, Branduardi D, Masetti M, De Vivo M, Motterlini R, Cavalli A. Theoretical insights into the mechanism of carbon monoxide (CO) release from CO-releasing molecules. Chemistry 2012; 18: 9267-9275.
16. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 2002; 90: E17-E24.
17. Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003; 93: e2-e8.
18. Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 2010; 9: 728-743.
19. Motterlini R, Sawle P, Hammad J, Bains S, Alberto R, Foresti R et al. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J 2005; 19: 284-286.
20. Vera T, Henegar JR, Drummond HA, Rimoldi JM, Stec DE. Protective effect of carbon monoxide-releasing compounds in ischemia-induced acute renal failure. J Am Soc Nephrol 2005; 16: 950-958.
21. Ryan MJ, Jernigan NL, Drummond HA, McLemore Jr GR, Rimoldi JM, Poreddy SR et al. Renal vascular responses to CORM-A1 in the mouse. Pharmacol Res 2006; 54: 24-29.
22. Csongradi E, Juncos LA, Drummond HA, Vera T, Stec DE. Role of carbon monoxide in kidney function: is a little carbon monoxide good for the kidney? Curr Pharm Biotechnol 2012; 13: 819-826.
23. Suliman HB, Carraway MS, Tatro LG, Piantadosi CA. A new activating role for CO in cardiac mitochondrial biogenesis. J Cell Sci 2007; 120: 299-308.
24. Suliman HB, Carraway MS, Ali AS, Reynolds CM, Welty-Wolf KE, Piantadosi CA. The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J Clin Invest 2007; 117: 3730-3741.
25. Rhodes MA, Carraway MS, Piantadosi CA, Reynolds CM, Cherry AD, Wester TE et al. Carbon monoxide, skeletal muscle oxidative stress, and mitochondrial biogenesis in humans. Am J Physiol Heart Circ Physiol 2009; 297: H392-H399.
26. Piantadosi CA, Carraway MS, Babiker A, Suliman HB. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res 2008; 103: 1232-1240.
27. Almeida AS, Queiroga CS, Sousa MF, Alves PM, Vieira HL. Carbon monoxide modulates apoptosis by reinforcing oxidative metabolism in astrocytes: role of Bcl-2. J Biol Chem 2012; 287: 10761-10770.
28. Tsui TY, Obed A, Siu YT, Yet SF, Prantl L, Schlitt HJ et al. Carbon monoxide inhalation rescues mice from fulminant hepatitis through improving hepatic energy metabolism. Shock 2007; 27: 165-171.
29. Lancel S, Hassoun SM, Favory R, Decoster B, Motterlini R, Neviere R. Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis. J Pharmacol Exp Ther 2009; 329: 641-648.
30. Lancel S, Montaigne D, Marechal X, Marciniak C, Hassoun SM, Decoster B et al. Carbon monoxide improves cardiac function and mitochondrial population quality in a mouse model of metabolic syndrome. PLoS One 2012; 7: e41836.
31. Sandouka A, Balogun E, Foresti R, Mann BE, Johnson TR, Tayem Y et al. Carbon monoxide-releasing molecules (CO-RMs) modulate respiration in isolated mitochondria. Cell Mol Biol (Noisy-le-grand) 2005; 51: 425-432.
32. Lo IL, Boczkowski J, Zini R, Salouage I, Berdeaux A, Motterlini R et al. A carbon monoxide-releasing molecule (CORM-3) uncouples mitochondrial respiration and modulates the production of reactive oxygen species. Free Radic Biol Med 2011; 50: 1556-1564.
33. Cypess AM, Kahn CR. Brown fat as a therapy for obesity and diabetes. Curr Opin Endocrinol Diabetes Obes 2010; 17: 143-149.
34. Tseng YH, Cypess AM, Kahn CR. Cellular bioenergetics as a target for obesity therapy. Nat Rev Drug Discov 2010; 9: 465-482.
35. Ziouzenkova O, Orasanu G, Sharlach M, Akiyama TE, Berger JP, Viereck J et al. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med 2007; 13: 695-702.
36. Schwarz EJ, Reginato MJ, Shao D, Krakow SL, Lazar MA. Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription. Mol Cell Biol 1997; 17: 1552-1561.
37. Villarroya F, Iglesias R, Giralt M. Retinoids and retinoid receptors in the control of energy balance: novel pharmacological strategies in obesity and diabetes. Curr Med Chem 2004; 11: 795-805.
38. Kiefer FW, Vernochet C, O'Brien P, Spoerl S, Brown JD, Nallamshetty S et al. Retinaldehyde dehydrogenase 1 regulates a thermogenic program in white adipose tissue. Nat Med 2012; 18: 918-925.
39. Shukla V, Singh SN, Vats P, Singh VK, Singh SB, Banerjee PK. Ghrelin and leptin levels of sojourners and acclimatized lowlanders and high altitude. Nutr Neurosci 2005; 8: 161-165.
40. Vats P, Singh VK, Singh SN, Singh SB. High altitude induced anorexia: effect of changes in leptin and oxidative stress levels. Nutr Neurosci 2007; 10: 243-249.
41. Norese M, Lezo?n CE, Alippi RM, Martnez MP, Conti MI, Bozzini CE. Failure of polycythemia-induced increase in arterial oxygen content to supress the anorexic effect of simulated high altitude in the adult rat. High Alt Med Biol 2002; 3: 49-57.